Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEGASUS: A Prospective obsErvational Study in Patients With Wet aGe-related Macular Degeneration or Diabetic Macular Edema to ASsess the Use of Intravitreal Aflibercept in roUtine Clinical practiceS in Canada

NCT02540369 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02540369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02540369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEGASUS: A Prospective obsErvational Study in Patients With Wet aGe-related Macular Degeneration or Diabetic Macular Edema to ASsess the Use of Intravitreal Aflibercept in roUtine Clinical practiceS in Canada
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
December 14, 2015
Completion date
January 26, 2018
Enrollment
2,150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet macular degeneration